MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-23-2026
Chembio Diagnostics Cash and Cash Equivalents 2011-2026 | CEMI
Annual Cash and Cash Equivalents Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.2 M | 28.8 M | 23.1 M | 18.3 M | 12.5 M | 3.79 M | 10.6 M | 5.38 M | 4.61 M | 9.65 M | 2.95 M | 3.01 M | 2.14 M | 1.07 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 28.8 M | 1.07 M | 10.3 M |
Quarterly Cash and Cash Equivalents Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 21.1 M | 22.8 M | 24.4 M | 28.8 M | 36 M | 5.56 M | 14.4 M | 23.1 M | 28.7 M | 36.4 M | 11.2 M | 18.3 M | 21.9 M | 4.5 M | 7.37 M | 12.5 M | 6.85 M | 9.51 M | 12.5 M | 3.79 M | 1.87 M | 3.69 M | 5.58 M | 10.6 M | 12.2 M | 1.44 M | 2.66 M | 5.38 M | 1.1 M | 1.56 M | 2.82 M | 4.61 M | 3.67 M | 6.84 M | 9.09 M | 9.65 M | 8.05 M | 8.65 M | 2.6 M | 2.95 M | 3.29 M | 4.39 M | 2.95 M | 3.01 M | 3.05 M | 2.14 B | 3.01 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.14 B | 1.1 M | 55.6 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
166 M | $ 88.4 | -4.4 % | $ 4.13 B | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 5.87 | 1.91 % | $ 7.81 M | USA |
 |
Castle Biosciences
CSTL
|
117 M | $ 21.09 | -2.36 % | $ 611 M | USA |
 |
Fulgent Genetics
FLGT
|
50.2 M | $ 18.88 | -3.18 % | $ 581 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
15.1 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
378 M | $ 126.53 | -4.91 % | $ 15.9 B | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.67 | -6.7 % | $ 7.39 M | USA |
 |
Illumina
ILMN
|
1.42 B | $ 161.59 | -3.85 % | $ 25 B | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 22.23 | -3.87 % | $ 1.18 B | USA |
 |
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
647 M | $ 149.63 | -2.07 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 100.78 | -1.98 % | $ 6.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.02 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 10.84 | -4.16 % | $ 1.39 B | USA |
 |
Natera
NTRA
|
1.08 B | $ 216.4 | -2.57 % | $ 29.6 B | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 181.01 | -2.59 % | $ 8.97 B | USA |
 |
Pacific Biosciences of California
PACB
|
63.7 M | $ 1.45 | -11.18 % | $ 435 M | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 454.25 | -0.97 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 151.0 | -2.5 % | $ 23.7 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.56 | -2.88 % | $ 422 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 19.13 | -3.16 % | $ 428 M | USA |
 |
Personalis
PSNL
|
124 M | $ 10.78 | -10.95 % | $ 962 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 26.03 | 0.13 % | $ 24.7 B |  Niderland |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 6.65 | -5.14 % | $ 277 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
70.1 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.08 | -3.19 % | $ 4.78 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 265.69 | 1.75 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 69.46 | -6.05 % | $ 4.15 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 470.97 | -2.3 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.68 | -0.95 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
588 M | $ 365.69 | -2.85 % | $ 21.8 B | USA |
 |
Neogen Corporation
NEOG
|
129 M | $ 8.83 | -3.18 % | $ 1.92 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 199.86 | 1.89 % | $ 22.2 B | USA |